Atherosclerosis I: Introduction
Atherosclerosis III: Management
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Cholesterol: Significance and Regulation
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Inflammation
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Nov 21, 2025

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Danni Li1, Aniqa B Alam2, Fang Yu3
1Department of Lab Medicine and Pathology, University of Minnesota, 420 Delaware Street SE, MMC 609, Minneapolis, MN, 55455, USA. dannili@umn.edu.
Long-chain sphingomyelin 41:1 (SM 41:1) was linked to better physical function in older adults. This specific sphingomyelin was cross-sectionally associated with improved performance on physical function tests and lower self-reported disability.
12:27A Pipeline to Investigate the Structures and Signaling Pathways of Sphingosine 1-Phosphate Receptors
Published on: June 8, 2022
07:29Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: